We are pleased to announce the acceptance for presentation of another Regenexx Research Paper at the Orthopedic Research Society this coming January. The paper is entitled: Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique. This is a 4 year study of 339 patients showing that the complications from stem cell injections (Regenexx-C) were far lower than those experienced by patients undergoing traditional orthopedic surgeries such as knee replacement. Knee outcome data will also be presented. This follows our presentation at ORS on orthopedic stem cells last year. We’re proud that the Centeno-Schultz clinic has again been chosen by the prestigious research organization to present our clinic’s data on this promising technique!